Two Sigma Securities’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-5,500
Closed -$238K – 3318
2024
Q1
$238K Buy
5,500
+800
+17% +$38.1K ﹤0.01% 2174
2023
Q4
$238K Sell
4,700
-4,000
-46% -$192K ﹤0.01% 2225
2023
Q3
$395K Sell
8,700
-1,400
-14% -$57.8K ﹤0.01% 1712
2023
Q2
$414K Buy
+10,100
New +$388K 0.01% 1579
2022
Q4
– Sell
-8,200
Closed -$363K – 2902
2022
Q3
$363K Buy
+8,200
New +$346K 0.01% 1382
2022
Q2
– Sell
-7,000
Closed -$259K – 2525
2022
Q1
$259K Buy
+7,000
New +$229K 0.01% 1528
2020
Q1
– Sell
-3,500
Closed -$211K – 1816
2019
Q4
$211K Sell
3,500
-2,800
-44% -$167K ﹤0.01% 2059
2019
Q3
$377K Buy
+6,300
New +$411K ﹤0.01% 1393
2019
Q1
– Sell
-6,000
Closed -$324K – 2130
2018
Q4
$324K Sell
6,000
-40,500
-87% -$2.07M ﹤0.01% 1301
2018
Q3
$2.4M Sell
46,500
-11,300
-20% -$531K 0.02% 624
2018
Q2
$2.41M Buy
57,800
+28,100
+95% +$1.25M 0.01% 810
2018
Q1
$1.31M Buy
+29,700
New +$1.51M 0.01% 1104

Other funds holding IONS

Two Sigma Securities's IONS Position: Q3 2026 in Review

Two Sigma Securities opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 9,581 shares worth $428K. The stake represents 0.03% of the portfolio and ranks #694 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in IONS as recently as Q4 2025.

Two Sigma Securities first reported a position in IONS in Q2 2017 and has held it in 14 quarters since. The position peaked at $3.82M in Q2 2024. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Two Sigma Securities held 9,581 shares of Ionis Pharmaceuticals worth $428K as of Q3 2026.
  • Ionis Pharmaceuticals was a new Two Sigma Securities position in Q3 2026.
  • Ionis Pharmaceuticals made up 0.03% of Two Sigma Securities's portfolio in Q3 2026, its #694 holding.
  • Two Sigma Securities first reported a position in Ionis Pharmaceuticals in Q2 2017 and has held it in 14 quarters since.
  • Two Sigma Securities's Ionis Pharmaceuticals position peaked at $3.82M in Q2 2024.
  • 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.